[ad_1]
The “Dow” index closed its best monthly performance in three decades on Monday, driven by positive signs of the possibility of obtaining a vaccine to combat the “Corona” virus.
Despite the weak session on Monday, in which the index fell 0.9%, the growth it achieved during the month of November reached 12%, thus achieving the best growth since January 1987.
Monday’s session saw a partial decline in the S&P 500 (0.5%) and the Nasdaq (0.1%).
And November earnings came to revive a sharp decline in financial markets in October, with growing concern over the lack of a vaccine for the virus and coinciding with the ambiguity of the US electoral scenario.
However, signs of recovery began to appear after the US elections, which took place on November 3, when the administration of US President Donald Trump approved the start of the process of transferring power to President-elect Joe Biden, despite the Trump’s continued efforts to stab him in the election results in the interests of his Democratic opponent.
With the clarity of the political scene, a set of good news arrived that yielded promising results from the trials of the “Moderna” and “Pfizer” vaccines, which eased the escalating rate of infection in the United States.
Moderna’s share increased by 20.2% after announcing the submission of a request to health authorities to approve its vaccine in the United States and Europe, after its full trials demonstrated its effectiveness by 94.1%.
[ad_2]
